Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37978951

Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 Feb 1
First author
Haas-Kogan DA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Haas-Kogan DA
      type
      Author
    2. name
      Aboian MS
      type
      Author
    3. name
      Minturn JE
      type
      Author
    4. name
      Leary SES
      type
      Author
    5. name
      Abdelbaki MS
      type
      Author
    6. name
      Goldman S
      type
      Author
    7. name
      Elster JD
      type
      Author
    8. name
      Kraya A
      type
      Author
    9. name
      Lueder MR
      type
      Author
    10. name
      Ramakrishnan D
      type
      Author
    11. name
      von Reppert M
      type
      Author
    12. name
      Liu KX
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Haas-Kogan DA
      type
      Author
    2. name
      Aboian MS
      type
      Author
    3. name
      Minturn JE
      type
      Author
    4. name
      Leary SES
      type
      Author
    5. name
      Abdelbaki MS
      type
      Author
    6. name
      Goldman S
      type
      Author
    7. name
      Elster JD
      type
      Author
    8. name
      Kraya A
      type
      Author
    9. name
      Lueder MR
      type
      Author
    10. name
      Ramakrishnan D
      type
      Author
    11. name
      von Reppert M
      type
      Author
    12. name
      Liu KX
      type
      Author
    bibliography ids
    1. nci-bib-33a31bd59818cb98d721d5e4
    book metadata
    content sha256
    f6d06409112b5b3af1c508d1067ca737c6103966e392f56fbc7cea7a62a0c42b
    document type
    citation
    dois
    1. 10.1200/JCO.23.01838
    electronic publication date
    display
    2023 Nov 17
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37978951
    immutable id
    pubmed:37978951@f6d06409112b5b3af1c508d1067ca737c6103966e392f56fbc7cea7a62a0c42b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    4
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    441-451
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37978951
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      47ba33e98bb6406ae2f99f0599fec298d51952ede9128f191bee90aac3235abb
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Feb 1
      precision
      day
      year
      2024
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37978951/
      title
      Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.

      Preserved source evidence · Not medical advice